Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2018	$ 8	$ 53,522	$ (52,684)	$ 846
Balance (in Shares) at Dec. 31, 2018	79,451,338
Exercise of stock options		10		10
Exercise of stock options (in Shares)	44,154
Issuance of stock in asset acquisition		109		109
Issuance of stock in asset acquisition (in Shares)	458,902
Issuance of warrants		38		38
Stock-based compensation expense		208		208
Stockholder distribution			(10)	(10)
Issuance of restricted stock
Issuance of restricted stock (in Shares)	446,333
Net loss			(14,901)	(14,901)
Balance at Dec. 31, 2019	$ 8	53,887	(67,595)	(13,700)
Balance (in Shares) at Dec. 31, 2019	80,400,727
Exercise of stock options		114		114
Exercise of stock options (in Shares)	488,625
Exercise of warrants		884		884
Exercise of warrants (in Shares)	4,995,584
Stock-based compensation expense		978		978
Conversion of convertible debt		17,446		17,446
Conversion of convertible debt (in Shares)	1,715,918
Issuance of restricted stock
Issuance of restricted stock (in Shares)	25,309
PIC shares recapitalized, net of issuance costs and the fair value of warrant liabilities (Restated)	$ 3	98,886		98,889
PIC shares recapitalized, net of issuance costs and the fair value of warrant liabilities (Restated) (in Shares)	28,739,091
Shares issued in offering, net of issuance costs	$ 2	144,889		144,891
Shares issued in offering, net of issuance costs (in Shares)	15,000,000
Net loss			(60,606)	(60,606)
Balance at Dec. 31, 2020	$ 13	$ 317,084	$ (128,201)	$ 188,896
Balance (in Shares) at Dec. 31, 2020	131,365,254